Is there any news that could impact the future trends of MIRO stock?

Yes, there is news that could impact the future trends of MIRO stock. <br/>1. Reviva Pharmaceuticals (RVPH) announced that its phase 3 trial assessing brilaroxazine in adults with schizophrenia reached its primary endpoint of safety, tolerability, and efficacy, causing RVPH shares to surge 47%. This could potentially have a positive impact on MIRO stock as it is also a healthcare company working on developing bioengineered organs composed of human cells. <br/>2. United Therapeutics (UTHR) announced its acquisition of Miromatrix Medical (MIRO) for $91.00 million in cash, which is expected to be completed in Q4 of 2023. This acquisition could potentially have a positive impact on MIRO stock as it will result in MIRO becoming a subsidiary of United Therapeutics, which is a biotechnology company with six FDA-approved therapies for rare conditions and a pipeline with four ongoing registration-phase studies. <br/>3. Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders in connection with Spirit Realty Capital, Inc.'s sale to Realty Income Corporation and Miromatrix Medical Inc.'s sale to United Therapeutics Corporation. This investigation could potentially impact the future trends of MIRO stock if it is determined that the sales were not in the best interest of shareholders.